We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$7.26M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.86M
3
INCY icon
Incyte
INCY
+$6.31M
4
FIS icon
Fidelity National Information Services
FIS
+$5.73M
5
ABBV icon
AbbVie
ABBV
+$4.95M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LW icon
26
Lamb Weston
LW
$7.36B
$5.59M 0.65%
60,415
+40,681
+206% +$4.12M
GE icon
27
GE Aerospace
GE
$368B
$5.57M 0.65%
+63,091
New +$5.67M
TJX icon
28
TJX Companies
TJX
$176B
$5.46M 0.64%
61,428
+45,516
+286% +$4.01M
JD icon
29
JD.com
JD
$43.6B
$5.29M 0.62%
181,698
+78,404
+76% +$2.73M
NKE icon
30
Nike
NKE
$62.7B
$5.29M 0.62%
+55,306
New +$5.69M
SNOW icon
31
Snowflake
SNOW
$103B
$5.17M 0.61%
+33,864
New +$5.51M
MNST icon
32
Monster Beverage
MNST
$95.5B
$5.12M 0.6%
+96,743
New +$5.5M
PPG icon
33
PPG Industries
PPG
$25B
$5.02M 0.59%
38,662
+16,262
+73% +$2.28M
TXN icon
34
Texas Instruments
TXN
$255B
$4.98M 0.58%
31,310
+23,863
+320% +$4.07M
CCJ icon
35
Cameco
CCJ
$38.4B
$4.86M 0.57%
122,723
+109,208
+808% +$3.86M
FSLR icon
36
First Solar
FSLR
$22.1B
$4.78M 0.56%
29,608
+18,885
+176% +$3.52M
ORLY icon
37
O'Reilly Automotive
ORLY
$72.4B
$4.64M 0.54%
76,530
+71,415
+1,396% +$4.48M
XYZ
38
Block Inc
XYZ
$49.2B
$4.58M 0.54%
103,381
+98,112
+1,862% +$6.08M
AAL icon
39
American Airlines Group
AAL
$10.2B
$4.56M 0.53%
355,916
+273,757
+333% +$4.25M
KSS icon
40
Kohl's
KSS
$2.21B
$4.4M 0.51%
210,039
+88,274
+72% +$2.23M
AXP icon
41
American Express
AXP
$228B
$4.37M 0.51%
+29,286
New +$4.79M
DKNG icon
42
DraftKings
DKNG
$11.8B
$4.26M 0.5%
144,577
-25,771
-15% -$761K
AAPL icon
43
Apple
AAPL
$4.9T
$4.24M 0.5%
+24,771
New +$4.54M
GM icon
44
General Motors
GM
$80B
$4.24M 0.5%
128,523
+59,632
+87% +$2.12M
BA icon
45
Boeing
BA
$175B
$4.08M 0.48%
+21,271
New +$4.65M
IMGN
46
DELISTED
Immunogen Inc
IMGN
$3.79M 0.44%
238,930
+141,946
+146% +$2.36M
DEN
47
DELISTED
Denbury Inc.
DEN
$3.78M 0.44%
+38,547
New +$3.49M
WOLF icon
48
Wolfspeed
WOLF
$1.24B
$3.75M 0.44%
98,326
+76,949
+360% +$4.03M
MRVL icon
49
Marvell Technology
MRVL
$165B
$3.67M 0.43%
67,790
+42,734
+171% +$2.52M
WSM icon
50
Williams-Sonoma
WSM
$27.5B
$3.66M 0.43%
47,142
+32,102
+213% +$2.21M
1
2
3 4 5

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.